Top section
Top section
Centralisation, competitiveness and cyber-risk will be political flashpoints
Singapore's BW LPG brings $300m deal to build eight new ships
Qatari dairy company’s rights issue struggles to get done
More articles
More articles
More articles
-
AlzChem, the German speciality chemicals maker, has set the terms for the first Frankfurt IPO of 2017. -
Detsky Mir, the Russian toy retailer, has announced the price range for its Moscow IPO, which could value the business at up to Rb77.6bn ($1.3bn).
-
Few Indian IPOs can boast of having $6.4bn in excess demand, but BSE is one of them. The Bombay stock exchange operator completed bookbuilding for its Rp12.4bn ($182m) float this week, an extraordinary end to a sale first mooted over a decade ago. The pressure is now on its larger rival to do just as well, writes John Loh.
-
Shares in Novartis closed 2.5% higher on Wednesday after it delivered its full year results presentation, in which it announced a share buyback programme and said it was considering options for its struggling eye care division Alcon, which makes contact lenses and eye medicines.
-
Banco Santander made a profit of €6.2bn last year as a booming performance in Latin American markets helped offset its exposure to a sinking pound.
-
In a relatively quiet week for live equity deals, Novartis, one of Europe’s largest pharmaceutical companies, has said it is considering an IPO or spin-off of its eye care division, and a real estate investment trust announced the year’s first London IPO of significant size.
Sub-sections
shared comment list
